FindTrial
Sign In

Role and Mechanisms of Circulating Tumor Cells in Postoperative Recurrence and Metastasis of Pancreatic Cancer

Role and Mechanisms of Circulating Tumor Cells in Postoperative Recurrence and Metastasis of Pancreatic Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105237
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Observation group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old, male or female, ECOG performance status score 0-1; 2. Pancreatic cancer diagnosed by histopathology and treated with surgery; 3. No basic diseases such as severe cardiopulmonary dysfunction.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of other malignant tumors; 2. High-risk population of loss to follow-up (no fixed residence, refused to sign informed consent); 3. Perioperative death (within 30 days after surgery) or severe complications (such as grade C pancreatic fistula, abdominal infection requiring reoperation).

Design outcomes

Primary

MeasureTime frame
Clinical prognosis;—

Countries

China

Contacts

Public ContactZhong Wu

West China Hospital of Sichuan University

wuzhong0057@163.com+86 189 8060 6518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026